Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Review Article

Insights into the Mechanism of Osteoporosis and the Available Treatment Options

Author(s): Rajeshwari Muniyasamy and Inderchand Manjubala*

Volume 25, Issue 12, 2024

Published on: 02 November, 2023

Page: [1538 - 1551] Pages: 14

DOI: 10.2174/0113892010273783231027073117

Price: $65

Abstract

Osteoporosis, one of the most prevalent bone illnesses, majorly affects postmenopausal women and men over 50 years of age. Osteoporosis is associated with an increased susceptibility to fragility fractures and can result in persistent pain and significant impairment in affected individuals. The primary method for diagnosing osteoporosis involves the assessment of bone mineral density (BMD) through the utilisation of dual energy x-ray absorptiometry (DEXA). The integration of a fracture risk assessment algorithm with bone mineral density (BMD) has led to significant progress in the diagnosis of osteoporosis. Given that osteoporosis is a chronic condition and multiple factors play an important role in maintaining bone mass, comprehending its underlying mechanism is crucial for developing more effective pharmaceutical interventions for the disease. The effective management of osteoporosis involves the utilisation of appropriate pharmacological agents in conjunction with suitable dietary interventions and lifestyle modifications. This review provides a comprehensive understanding of the types of osteoporosis and elucidates the currently available pharmacological treatment options and their related mechanism of action and usage.

Keywords: Primary and secondary osteoporosis, mechanism of osteoporosis, treatment options, anti-resorptive agents, anabolic therapy, bone mineral density, hormone replacement therapy.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy